Skip to Main Content

Paper Details

Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
Proc Natl Acad Sci U S A
97
2019
ANO2, Anoctamin 2, Anti-ANO2 antibody, EBNA1, EBNA1 peptides, EBV, EBV nuclear antigen 1, Epstein, Epstein-Barr virus, Epstein-Barr virus nuclear antigen 1, HLA, HLA gene region, HLA-A*02, HLA-A*02:01, HLA-DRB1, HLA-DRB1*04:01 haplotype, HLA-DRB1*15:01, IgG, IgG antibody, MS, Multiple sclerosis, T cell, aa 140 to 149, anti-ANO2 antibody, anti-EBNA1 antibody, autoimmune disease of the central nervous system, chloride, chloride-channel protein, inflammatory disease, multiple sclerosis, patients, plasma
Author NameAffiliation
Burcu AyogluDivision of Cellular and Clinical Proteomics, KTH - Royal Institute of Technology
Izaura Lima BomfimKarolinska Institute
Izaura Lima BomfimKarolinska University Hospital
Leonid PadyukovKarolinska University Hospital
Leonid PadyukovKarolinska Institutet
Elisabet SvenungssonKarolinska Institutet
Alexander DiltheyUniversity of Oxford
Alexander DiltheyInstitute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University Dusseldorf
Jan HillertKarolinska Institute
Lars AlfredssonInstitute of Environmental Medicine, Karolinska Institute
Lars Alfredsson
Peter NilssonKTH - Royal Institute of Technology
Tomas OlssonKarolinska Institute
Tomas OlssonKarolinska University Hospital
Ingrid KockumKarolinska Institute
Ingrid KockumKarolinska University Hospital
  • 1 - 16

Datasets

Release 1.2